etoposide has been researched along with quercetin in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.56) | 18.2507 |
| 2000's | 15 (41.67) | 29.6817 |
| 2010's | 17 (47.22) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brouard, I; Burmistrova, O; Estévez, F; Estévez, S; Marrero, MT; Quintana, J; Welsch, I | 1 |
| Bae, M; Choi, SU; Choi, SZ; Kim, CS; Kim, SY; Lee, KR; Oh, DC; Oh, J; Son, MW; Subedi, L; Suh, WS | 1 |
| Corbett, AH; Osheroff, N; Robinson, MJ | 1 |
| Ling, V; Shapiro, AB | 1 |
| Gawron, A; Jakubowicz-Gil, J; Kandefer-Szerszeń, M; Paduch, R | 2 |
| Chowdhury, AR; Goswami, A; Majumder, HK; Mandal, S; Mukhopadhyay, S; Sharma, S | 1 |
| Cierniak, A; Kapiszewska, M; Papiez, M | 1 |
| Dechsupa, S; Kothan, S; Leger, G; Mankhetkorn, S; Moretti, JL; Vergote, J | 1 |
| Mikhailenko, VM; Philchenkov, AA; Zavelevich, MP | 1 |
| Cierniak, A; Kapiszewska, M; Lomnicki, A; Papiez, MA; Pietrzycka, A; Stepniewski, M | 1 |
| Cierniak, A; Elas, M; Kapiszewska, M; Lankoff, A | 1 |
| Barjesteh van Waalwijk van Doorn-Khosrovani, S; Godschalk, RW; Janssen, J; Maas, LM; Nijhuis, JG; van Schooten, FJ | 1 |
| Choi, JS; Li, X | 1 |
| Green, KK; Keen, CL; Kwik-Uribe, C; Lanoue, L | 1 |
| Blokhin, D; Philchenkov, A; Savinska, L; Zavelevich, M | 1 |
| Fadlalla, K; Katkoori, V; Manne, U; Mosley, L; Samuel, T; Turner, T | 1 |
| Choe, W; Chung, SH; Ha, J; Kang, I; Kim, HS; Kim, SS; Lee, S; Lim, JS; Wannatung, T; Yang, WK | 1 |
| Papież, MA | 1 |
| Fatma, S; Goswami, DG; Iqbal, Z; Negi, LM; Panda, AK; Talegaonkar, S; Tariq, M | 1 |
| Krzyściak, W; Papież, MA | 1 |
| Cao, Y; Feng, F; Hou, MX; Jia, H; Jiang, QY; Ma, HD; Sun, HW; Wang, T; Yang, Q; Yang, YP | 1 |
| Aqaqe, N; Biechonski, S; Elad, D; Gourevich, D; Grisaru, D; Jaffa, AJ; Milyavsky, M; Olender, L; Rall, M; Raz, Y; Trakhtenbrot, L; Wiesmuller, L; Yassin, M; Zipin-Roitman, A | 1 |
| Britt, RD; Kirkland, JL; LeBrasseur, N; Manlove, LJ; Pabelick, CM; Parikh, P; Prakash, YS; Ravix, J; Roesler, A; Sieck, GC; Teske, J; Thompson, MA; Tschumperlin, DJ; Wicher, SA | 1 |
| Berman, C; Emmanuel, F; Goodenow, D; Richardson, C; Sahyouni, M | 1 |
| Florian-Rodriguez, ME; Gaddam, NG; Hare, AM; Keller, P; Shi, H; Word, RA | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
36 other study(ies) available for etoposide and quercetin
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and effects on cell viability of flavonols and 3-methyl ether derivatives on human leukemia cells.
Topics: Antineoplastic Agents; Cell Death; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonols; HL-60 Cells; Humans; Methyl Ethers; Molecular Structure; Structure-Activity Relationship; U937 Cells | 2014 |
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biflavonoids; Glycosides; Humans; Impatiens; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; Neuroprotective Agents; Nitric Oxide; Nuclear Magnetic Resonance, Biomolecular; Republic of Korea | 2017 |
Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
Topics: Adenosine Triphosphate; Amsacrine; Animals; Anti-Infective Agents; Antineoplastic Agents; Binding Sites; Cell Nucleus; DNA Topoisomerases, Type II; DNA, Bacterial; Drosophila melanogaster; Escherichia coli; Etoposide; Fluoroquinolones; Genistein; Hydrolysis; Isoflavones; Novobiocin; Plasmids; Quercetin; Quinolones; Topoisomerase II Inhibitors | 1993 |
Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Binding Sites; Biological Transport; Cell Line; Cell Membrane; Colchicine; Cricetinae; Cricetulus; Dactinomycin; Daunorubicin; Doxorubicin; Etoposide; Fluorescence; Fluorescent Dyes; Kinetics; Liposomes; Protein Binding; Quercetin; Rhodamine 123; Rhodamines; Vinblastine | 1997 |
The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Culture Techniques; Cell Transformation, Neoplastic; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Eukaryotic Cells; Fibroblasts; Heat-Shock Proteins; HeLa Cells; Hot Temperature; HSP27 Heat-Shock Proteins; Humans; Models, Biological; Molecular Chaperones; Neoplasm Proteins; Neoplasms; Quercetin; Stress, Physiological | 2002 |
Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I.
Topics: Amsacrine; Animals; Antineoplastic Agents; Base Sequence; Betulinic Acid; Catalysis; Cell Nucleus; DNA, Superhelical; Enzyme Inhibitors; Etoposide; Flavonoids; Kinetics; Liver; Luteolin; Nucleic Acid Denaturation; Oligodeoxyribonucleotides; Pentacyclic Triterpenes; Plant Leaves; Quercetin; Rats; Spectrometry, Fluorescence; Topoisomerase I Inhibitors; Triterpenes | 2002 |
The effect of cisplatin, etoposide and quercetin on Hsp72 expression.
Topics: Antineoplastic Agents; Blotting, Western; Cisplatin; Etoposide; Fibroblasts; Heat-Shock Proteins; HeLa Cells; Hot Temperature; HSP72 Heat-Shock Proteins; Humans; Laryngeal Neoplasms; Lung Neoplasms; Quercetin; Skin; Tumor Cells, Cultured | 2002 |
Modulatory effect of quercetin on DNA damage, induced by etoposide in bone marrow cells and on changes in the activity of antioxidant enzymes in rats.
Topics: Animals; Bone Marrow Cells; Catalase; DNA Damage; Etoposide; Male; Quercetin; Rats; Rats, Wistar; Superoxide Dismutase | 2004 |
Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells.
Topics: Annexins; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; K562 Cells; Membrane Potentials; Mitochondria; Quercetin; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2004 |
Analysis of 1H NMR-detectable mobile lipid domains for assessment of apoptosis induced by inhibitors of DNA synthesis and replication.
Topics: Apoptosis; Cell Line, Tumor; Cell Membrane; DNA Replication; Etoposide; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Membrane Lipids; Quercetin; Vidarabine | 2005 |
Prolonged quercetin administration diminishes the etoposide-induced DNA damage in bone marrow cells of rats.
Topics: Animals; Bone Marrow Cells; Catalase; Comet Assay; DNA Damage; Etoposide; Female; Fluorescence Recovery After Photobleaching; Injections, Subcutaneous; Linear Models; Lung; Quercetin; Rats; Rats, Wistar; Superoxide Dismutase | 2007 |
Lifespan of etoposide-treated human neutrophils is affected by antioxidant ability of quercetin.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; DNA Damage; Etoposide; Humans; Hydrogen Peroxide; Neutrophils; Peroxidase; Phenols; Quercetin; Reactive Oxygen Species | 2007 |
Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
Topics: Antigens, CD34; Cells, Cultured; Dietary Supplements; DNA Breaks, Double-Stranded; Etoposide; Flavonoids; Genistein; Histone-Lysine N-Methyltransferase; Humans; Kaempferols; Leukemia; Leukocytes, Mononuclear; Myeloid-Lymphoid Leukemia Protein; Quercetin; Translocation, Genetic | 2007 |
Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Etoposide; Infusions, Intravenous; Male; Metabolic Clearance Rate; Quercetin; Rats; Rats, Sprague-Dawley | 2009 |
Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity.
Topics: Cacao; Cell Line; Diet; Dimerization; Etoposide; Female; Flavonoids; HL-60 Cells; Humans; Infant; Leukemia, Myeloid, Acute; Pregnancy; Prenatal Exposure Delayed Effects; Quercetin; Risk Factors; Topoisomerase II Inhibitors | 2010 |
Jurkat/A4 cells with multidrug resistance exhibit reduced sensitivity to quercetin.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Separation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Gene Expression; Gene Expression Profiling; Humans; Jurkat Cells; Quercetin | 2010 |
Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Drug Synergism; Etoposide; Flow Cytometry; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Male; Prostatic Neoplasms; Quercetin; Survivin; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2012 |
Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Etoposide; Genes, Reporter; Humans; Hypoxia-Inducible Factor 1; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quercetin; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
The effect of quercetin on oxidative DNA damage and myelosuppression induced by etoposide in bone marrow cells of rats.
Topics: Animals; Antioxidants; Apoptosis; Bone Marrow Cells; DNA Damage; Etoposide; Humans; Leukemia, Myeloid, Acute; Oxidation-Reduction; Quercetin; Rats | 2014 |
Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Breast Neoplasms; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Etoposide; Female; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Intestinal Absorption; Lactic Acid; Male; MCF-7 Cells; Microscopy, Confocal; Nanoparticles; Nanotechnology; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Quercetin; Rats, Wistar; Rhodamines; Solubility; Sonication; Technology, Pharmaceutical | 2016 |
The antioxidant quercetin protects HL-60 cells with high myeloperoxidase activity against pro-oxidative and apoptotic effects of etoposide.
Topics: Antioxidants; Apoptosis; Etoposide; HL-60 Cells; Humans; Oxidation-Reduction; Peroxidase; Quercetin; Reactive Oxygen Species | 2014 |
Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Male; Mice, SCID; MicroRNAs; Niacinamide; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; Quercetin; Receptor, Notch1; Signal Transduction; Sorafenib; Transfection; Xenograft Model Antitumor Assays | 2016 |
Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
Topics: Adult; Ascorbic Acid; Cell Culture Techniques; Cell Transformation, Neoplastic; Cells, Cultured; Colony-Forming Units Assay; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Female; Genistein; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Infant; Leukemia; Maternal-Fetal Exchange; Myeloid-Lymphoid Leukemia Protein; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pregnancy; Quercetin; Signal Transduction; Topoisomerase II Inhibitors | 2017 |
Hyperoxia-induced Cellular Senescence in Fetal Airway Smooth Muscle Cells.
Topics: Biomarkers; Cell Cycle; Cellular Senescence; Cytokines; Dasatinib; DNA Damage; Etoposide; Extracellular Matrix; Extracellular Matrix Proteins; Fetus; Humans; Hyperoxia; Inflammation Mediators; Lung; Models, Biological; Myocytes, Smooth Muscle; Phenotype; Quercetin | 2019 |
Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
Topics: Animals; Cell Line; Chromosome Breakpoints; Chromosomes, Mammalian; Dexrazoxane; DNA; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; Etoposide; Flavonoids; Genistein; Histones; Kaempferols; Luteolin; Mice; Mouse Embryonic Stem Cells; Quercetin; Topoisomerase II Inhibitors; Translocation, Genetic | 2020 |
Induction of Cellular Senescence in Rat Vaginal Fibroblasts and Treatment With Senolytics: An in Vitro Model for the Study of Pelvic Organ Prolapse.
Topics: Animals; Biomarkers; Cellular Senescence; Dasatinib; Etoposide; Female; Fibroblasts; Humans; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Pelvic Organ Prolapse; Quercetin; Rats; Senotherapeutics | 2022 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |